Session 3: The Impact of Depression on Chronic Diseases: Optimizing Clinical Outcomes in the Treatment of Major Depressive Disorder (MDD).

Date: 1/28/2012 Check-In and Breakfast:
7:00 am - 7:30 am
Educational Session: 7:30 am - 1:00 pm
Sharm Steadman

M. Sharm Steadman, Pharm D, BCPS, CDE, FASHP

Professor, Department of Family & Preventative Medicine, Family Practice Residency Program, University of South Carolina, Columbia, SC

At the conclusion of this program, the participant should be able to:

  • Discuss the impact of depression on patient adherence and ability to make effective behavior change.
  • Review evidence on the impact of depression on clinical outcomes in patients with cardiovascular disease including strokes, chronic heart failure and myocardial infarctions.
  • Discuss the role of emotional distress in diabetes: recognizing and overcoming ‘diabetes burnout’.
  • Discuss initiation, appropriate titration and duration of antidepressant therapy to achieve optimal clinical outcomes.
  • Describe the role of measurement based tools in diagnosis and evaluation of clinical response in patients with depression.
  • Evaluate the evidence for the role of new antidepressant products and formulations.